Pfizer's Hopes For Landmark Merger Dim As Deadline Nears
Pfizer Inc. has until Monday to hash out a blockbuster tie-up agreement with British rival AstraZeneca PLC, but the prospective deal's chances grow slimmer by the day as the target company...To view the full article, register now.
Already a subscriber? Click here to view full article